Tuoyi

toripalimab · Shanghai Junshi Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tuoyi, covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases [Phase 1, Phase 2]